These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 21328989)
21. Anti-arrhythmic effects of kappa-opioid receptor and its changes in ischemia and reperfusion. Jin-Cheng L; Wen Y; Zhao Y; Quan-Yu Z; Shu-Miao Z; Hai-Tao G; Hui B; Yue-Min W; Xin S; Liang C; Qin C; Shi-Qiang Y; Kaye AD; Ding-Hua Y; Jian-Ming P Arch Med Res; 2008 Jul; 39(5):483-8. PubMed ID: 18514092 [TBL] [Abstract][Full Text] [Related]
22. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes. Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329 [TBL] [Abstract][Full Text] [Related]
23. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. Suarez-Roca H; Maixner W J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733 [TBL] [Abstract][Full Text] [Related]
24. Effects of pharmacological preconditioning with U50488H on calcium homeostasis in rat ventricular myocytes subjected to metabolic inhibition and anoxia. Ho JC; Wu S; Kam KW; Sham JS; Wong TM Br J Pharmacol; 2002 Nov; 137(6):739-48. PubMed ID: 12411403 [TBL] [Abstract][Full Text] [Related]
25. Cross-talk between cardiac kappa-opioid and beta-adrenergic receptors in developing hypertensive rats. Yu XC; Wang HX; Zhang WM; Wong TM J Mol Cell Cardiol; 1999 Mar; 31(3):597-605. PubMed ID: 10198190 [TBL] [Abstract][Full Text] [Related]
26. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart. Bian JS; Zhang WM; Pei JM; Wong TM J Pharmacol Exp Ther; 2000 Mar; 292(3):1065-70. PubMed ID: 10688624 [TBL] [Abstract][Full Text] [Related]
27. Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction. Weil J; Zolk O; Griepentrog J; Wenzel U; Zimmermann WH; Eschenhagen T Cardiovasc Res; 2006 Feb; 69(2):412-22. PubMed ID: 16376326 [TBL] [Abstract][Full Text] [Related]
28. Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced histopathology. Bausch SB; Esteb TM; Terman GW; Chavkin C J Pharmacol Exp Ther; 1998 Mar; 284(3):1147-55. PubMed ID: 9495877 [TBL] [Abstract][Full Text] [Related]
29. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus. Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735 [TBL] [Abstract][Full Text] [Related]
30. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts. Peart JN; Gross ER; Reichelt ME; Hsu A; Headrick JP; Gross GJ Basic Res Cardiol; 2008 Sep; 103(5):454-63. PubMed ID: 18500486 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors. Utz J; Eckert R; Trautwein W J Pharmacol Exp Ther; 1995 Aug; 274(2):627-33. PubMed ID: 7543570 [TBL] [Abstract][Full Text] [Related]
32. [The effect of chelerythrine on the hypertrophy of cardiac myocytes of neonatal rats induced by different glucose levels and its mechanism]. Zhang WB; Wang M; Zhou BQ; Zhu JH; Fu GS Yao Xue Xue Bao; 2009 Feb; 44(2):115-20. PubMed ID: 19408678 [TBL] [Abstract][Full Text] [Related]
33. The kappa opioid agonist U50,488 potentiates 6-hydroxydopamine-induced neurotoxicity on dopaminergic neurons. Marin C; Bové J; Serrats J; Cortés R; Mengod G; Tolosa E Exp Neurol; 2005 Jan; 191(1):41-52. PubMed ID: 15589511 [TBL] [Abstract][Full Text] [Related]
34. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum. Mitrovic I; Napier TC J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342 [TBL] [Abstract][Full Text] [Related]
35. [Interaction between opioid receptor and adrenoceptor signaling in ischemia reperfusion of the isolated rat heart]. Yang SL; Xia Q; Shen YL; Zhou SY Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 32(3):187-91. PubMed ID: 12881860 [TBL] [Abstract][Full Text] [Related]
36. [The elects of pH on the calcium homeostasis upon the kappa-opioid receptor stimulation in the myocytes]. Pei JM; Wang YM; Chem M Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2001 Aug; 17(3):223, 230. PubMed ID: 21189613 [No Abstract] [Full Text] [Related]
37. [Effects of kappa-opioid receptor stimulation on high glucose induced myocardial hypertrophy of neonatal rats]. Liu DM; Wang HX; Zhang L; Lu ML; Wu GQ Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Nov; 26(4):463-5. PubMed ID: 21328989 [TBL] [Abstract][Full Text] [Related]
38. [Comparing effects of U50488H, prazosin and/or propranolol on cardiac hypertrophy induced by NE in rat]. Wang GJ; Yao YS; Wang HX Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Feb; 26(1):82-5. PubMed ID: 20476574 [TBL] [Abstract][Full Text] [Related]
39. [Inhibitory effects of kappa-opioid receptor stimulation on cultured myocardial cells]. Yang YL; Wang HX; Yang YH Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2002 Nov; 18(4):358-61. PubMed ID: 21174814 [TBL] [Abstract][Full Text] [Related]
40. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B). Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]